NBIX - Neurocrine Biosciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

NBIX is currently covered by 21 analysts with an average price target of $193.21. This is a potential upside of $36.62 (23.39%) from yesterday's end of day stock price of $156.59.

Neurocrine Biosciences's activity chart (see below) currently has 849 price targets and 601 ratings on display. The stock rating distribution of NBIX is 82.09% BUY and 17.91% HOLD.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 82.41% of the time, taking 318.59 days on average.

Highest price target for NBIX is $253, Lowest price target is $140, average price target is $193.21.

Most recent stock forecast was given by JEFFREY HUNG from MORGAN STANLEY on 12-Nov-2026. First documented stock forecast 15-Dec-2014.

Best performing analysts who are covering NBIX - Neurocrine Biosciences:

Cory Kasimov Ami Fadia Yatin Suneja Andrew Fein Joshua Schimmer Danielle Brill Jay Olson

Currently out of the existing stock ratings of NBIX, 12 are a HOLD (17.91%), 55 are a BUY (82.09%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 09-Apr-2026

$191

$21.6 (12.75%)

$185

7 days ago
(12-Nov-2026)

30/36 (83.33%)

$21.6 (12.75%)

439

Buy Since 13-Oct-2024

$215

$45.6 (26.92%)

$210

17 days ago
(02-Nov-2026)

24/27 (88.89%)

$69.65 (47.92%)

388

Buy Since 05-May-2025

$190

$20.6 (12.16%)

$198

17 days ago
(02-Nov-2026)

43/47 (91.49%)

$44.65 (30.72%)

153

Buy Since 01-Aug-2023

$220

$50.6 (29.87%)

$200

17 days ago
(02-Nov-2026)

20/22 (90.91%)

$74.65 (51.36%)

398

Buy Since 05-May-2025

$204

$34.6 (20.43%)

$204

1 months 4 days ago
(15-Oct-2026)

6/8 (75%)

$68.29 (50.32%)

181

Show more analysts

Please expand the browser size to see the chart

What is NBIX (Neurocrine Biosciences) average time for price targets to be met?

On average it took 319 days for the stock forecasts to be reached, with an average price target met ratio of 82.41%.

Which analyst most recently updated their price target on NBIX (Neurocrine Biosciences)?

Jeffrey Hung

Which analyst has the most public recommendations on NBIX (Neurocrine Biosciences)?

Jeffrey Hung works at MORGAN STANLEY and has 7 price targets and 6 ratings on NBIX

Which analyst is the currently most bullish on NBIX (Neurocrine Biosciences)?

Yigal Nochomovitz with the highest potential upside of $83.6

Which analyst is the currently most reserved on NBIX (Neurocrine Biosciences)?

Ian Somaiya with the lowest potential downside of -$94.4
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?